Welcome to Markets Desk, let's get you caught up on the stories moving the needle today.
The United States is putting its weight behind a fourteen billion dollar subsea internet cable designed to link Thailand and five other Southeast Asian nations directly to American infrastructure, deliberately routing around the South China Sea. The U.S. Trade and Development Agency confirmed funding for a feasibility study, framing this as a strategic move to keep the region's digital backbone out of China's reach.
Shifting to biotech, Avalyn Pharma is drawing attention after Respiratory Research published Phase one trial data on AP zero two, the company's nebulized formulation of nintedanib targeting lung disease. Results covered both healthy volunteers and patients with idiopathic pulmonary fibrosis, a notoriously difficult condition to treat, giving investors an early but meaningful clinical signal to watch.
And on the corporate governance front, PetMed Express, the parent of PetCareRx, has named Tamar Elkeles as an independent director and Chair of the Compensation and Human Capital Committee, effective September seventeenth, two thousand twenty six. The appointment signals the company is shoring up board-level oversight at a time when the pet health space remains competitive and margin-sensitive.
That's the tape. Markets Desk, signing off the floor.
